v3.26.1
Equity method investments (Tables)
6 Months Ended
Jun. 30, 2026
Equity Method Investments and Joint Ventures [Abstract]  
Summary of carrying value and fair value of investments

Our investments in Kraft Heinz, Occidental and Berkadia are summarized as follows (in millions). Kraft Heinz and Occidental common stocks are publicly-traded and the fair values are based on quoted market prices as of our balance sheet dates. The carrying values of Kraft Heinz and Occidental include reductions for other-than-temporary impairment losses recorded in the second and fourth quarters of 2025, respectively.

 

Carrying Value

 

 

Fair Value

 

 

June 30,
2026

 

 

December 31,
2025

 

 

June 30,
2026

 

 

December 31,
2025

 

Kraft Heinz

$

8,760

 

 

$

8,634

 

 

$

7,692

 

 

$

7,897

 

Occidental

 

10,727

 

 

 

10,894

 

 

 

12,868

 

 

 

10,894

 

Berkadia

 

461

 

 

 

450

 

 

 

 

 

 

 

 

$

19,948

 

 

$

19,978

 

 

 

 

 

 

 

Summary of earnings and distributions received from equity method investments

Our equity in earnings and distributions received from equity method investments are as follows (in millions).

 

Equity in Earnings

 

 

Distributions Received

 

 

Second Quarter

 

 

First Six Months

 

 

Second Quarter

 

 

First Six Months

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Kraft Heinz*

$

223

 

 

$

(4,991

)

 

$

403

 

 

$

(4,796

)

 

$

130

 

 

$

130

 

 

$

260

 

 

$

260

 

Occidental*

 

8

 

 

 

216

 

 

 

(10

)

 

 

134

 

 

 

68

 

 

 

64

 

 

 

132

 

 

 

120

 

Berkadia

 

17

 

 

 

30

 

 

 

31

 

 

 

43

 

 

 

11

 

 

 

29

 

 

 

20

 

 

 

38

 

 

$

248

 

 

$

(4,745

)

 

$

424

 

 

$

(4,619

)

 

$

209

 

 

$

223

 

 

$

412

 

 

$

418

 

——————

* We report our equity in Occidental’s earnings on a one-quarter lag and, beginning with the second quarter of 2025, we also report our equity in Kraft Heinz’s earnings on a one-quarter lag.

Summarized unaudited financial information

 

March 28,
 2026

 

 

September 27,
 2025

 

Assets

$

82,046

 

 

$

81,695

 

Liabilities

 

39,997

 

 

 

40,116

 

 

 

Quarter Ended
March 28, 2026

 

 

Quarter Ended
March 29, 2025

 

 

Six Months Ended
March 28, 2026

 

Net sales

$

6,047

 

 

$

5,999

 

 

$

12,401

 

Net earnings attributable to common shareholders

 

798

 

 

 

712

 

 

 

1,449

 

 

March 31,
2026

 

 

September 30,
2025

 

Assets

$

80,464

 

 

$

83,472

 

Liabilities

 

40,904

 

 

 

46,706

 

 

 

 

Quarter Ended March 31,

 

 

Six Months Ended March 31,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Total revenues and other income

$

5,109

 

 

$

5,738

 

 

$

10,532

 

 

$

11,458

 

Net earnings attributable to common shareholders

 

3,175

 

 

 

766

 

 

 

3,107

 

 

 

469

 

Net earnings attributable to Occidental’s common shareholders in its first quarter of 2026 included an after-tax gain of approximately $3.1 billion from its sale of OxyChem to Berkshire. Our equity in earnings for the second quarter of 2026 excluded our share of Occidental’s after-tax gain from this sale. The carrying value of our investment in Occidental common stock as of June 30, 2026 exceeded our share of Occidental common shareholders’ equity as of March 31, 2026 by approximately $2.5 billion.